CARL ZEISS MEDITEC ADR 1 (AFXA) — Tangible Net Worth Ratio
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Tangible Net Worth Ratio of 68.8% as of September 2025. This metric is calculated by deducting intangible assets (€662.87 Million) from net assets (€2.13 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CARL ZEISS MEDITEC ADR 1 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
CARL ZEISS MEDITEC ADR 1 Tangible Net Worth Ratio (2022–2025)
This chart shows how CARL ZEISS MEDITEC ADR 1's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of September 2025, the ratio stands at 68.8%, reflecting net assets of €2.13 Billion with intangible assets of €662.87 Million EUR. See AFXA defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for CARL ZEISS MEDITEC ADR 1 (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for CARL ZEISS MEDITEC ADR 1 from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see CARL ZEISS MEDITEC ADR 1 market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.8% | €2.13 Billion | €662.87 Million | €3.40 Billion | ▲ +3.2 pp |
| 2024 | 65.6% | €2.06 Billion | €706.85 Million | €3.39 Billion | ▼ -22.4 pp |
| 2023 | 88.1% | €2.17 Billion | €259.49 Million | €3.03 Billion | ▼ -0.1 pp |
| 2022 | 88.2% | €2.03 Billion | €240.43 Million | €2.82 Billion | — |